These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 37436975)

  • 21. A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid42 and DJ-1 in Human Cerebrospinal Fluid.
    Kruse N; Schlossmacher MG; Schulz-Schaeffer WJ; Vanmechelen E; Vanderstichele H; El-Agnaf OM; Mollenhauer B
    PLoS One; 2016; 11(4):e0153564. PubMed ID: 27116005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood biomarker-based classification study for neurodegenerative diseases.
    Kelly J; Moyeed R; Carroll C; Luo S; Li X
    Sci Rep; 2023 Oct; 13(1):17191. PubMed ID: 37821485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Creutzfeldt-jakob, Parkinson, lewy body dementia and Alzheimer diseases: from diagnosis to therapy.
    Dupiereux I; Zorzi W; Quadrio I; Perret-Liaudet A; Kovacs GG; Heinen E; Elmoualij B
    Cent Nerv Syst Agents Med Chem; 2009 Mar; 9(1):2-11. PubMed ID: 20021333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biosensor approaches on the diagnosis of neurodegenerative diseases: Sensing the past to the future.
    Karaboğa MNS; Sezgintürk MK
    J Pharm Biomed Anal; 2022 Feb; 209():114479. PubMed ID: 34861607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reconsidering red blood cells as the diagnostic potential for neurodegenerative disorders.
    Yadav S; Deepika ; Moar K; Kumar A; Khola N; Pant A; Kakde GS; Maurya PK
    Biol Cell; 2024 Jul; 116(7):e2400019. PubMed ID: 38822416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene Expression Profiling as a Novel Diagnostic Tool for Neurodegenerative Disorders.
    Martínez-Iglesias O; Naidoo V; Carril JC; Seoane S; Cacabelos N; Cacabelos R
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parkinson's disease biomarkers based on α-synuclein.
    Fayyad M; Salim S; Majbour N; Erskine D; Stoops E; Mollenhauer B; El-Agnaf OMA
    J Neurochem; 2019 Sep; 150(5):626-636. PubMed ID: 31265130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomarkers of neurodegenerative disorders: how good are they?
    Rachakonda V; Pan TH; LE WD
    Cell Res; 2004 Oct; 14(5):347-58. PubMed ID: 15538967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases.
    Sengupta U; Kayed R
    Prog Neurobiol; 2022 Jul; 214():102270. PubMed ID: 35447272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid.
    Shahnawaz M; Tokuda T; Waragai M; Mendez N; Ishii R; Trenkwalder C; Mollenhauer B; Soto C
    JAMA Neurol; 2017 Feb; 74(2):163-172. PubMed ID: 27918765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral Biomarkers for Early Detection of Alzheimer's and Parkinson's Diseases.
    Htike TT; Mishra S; Kumar S; Padmanabhan P; Gulyás B
    Mol Neurobiol; 2019 Mar; 56(3):2256-2277. PubMed ID: 30008073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Red Blood Cells' Thermodynamic Behavior in Neurodegenerative Pathologies and Aging.
    Todinova S; Krumova S; Bogdanova D; Danailova A; Zlatareva E; Kalaydzhiev N; Langari A; Milanov I; Taneva SG
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.
    Clark LF; Kodadek T
    ACS Chem Neurosci; 2016 May; 7(5):520-7. PubMed ID: 27046268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific Signatures of Serum miRNAs as Potential Biomarkers to Discriminate Clinically Similar Neurodegenerative and Vascular-Related Diseases.
    Barbagallo C; Mostile G; Baglieri G; Giunta F; Luca A; Raciti L; Zappia M; Purrello M; Ragusa M; Nicoletti A
    Cell Mol Neurobiol; 2020 May; 40(4):531-546. PubMed ID: 31691877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of microRNA-485 in neurodegenerative diseases.
    Ryu IS; Kim DH; Cho HJ; Ryu JH
    Rev Neurosci; 2023 Jan; 34(1):49-62. PubMed ID: 35793556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphorylated α-synuclein as a potential biomarker for Parkinson's disease and related disorders.
    Foulds P; Mann DM; Allsop D
    Expert Rev Mol Diagn; 2012 Mar; 12(2):115-7. PubMed ID: 22369370
    [No Abstract]   [Full Text] [Related]  

  • 37. Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment.
    Pathak N; Vimal SK; Tandon I; Agrawal L; Hongyi C; Bhattacharyya S
    Metab Brain Dis; 2022 Jan; 37(1):67-104. PubMed ID: 34719771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Olfactory Dysfunction in Neurodegenerative Diseases.
    Marin C; Vilas D; Langdon C; Alobid I; López-Chacón M; Haehner A; Hummel T; Mullol J
    Curr Allergy Asthma Rep; 2018 Jun; 18(8):42. PubMed ID: 29904888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Point-of-Care Devices Using Disease Biomarkers To Diagnose Neurodegenerative Disorders.
    Wei TY; Fu Y; Chang KH; Lin KJ; Lu YJ; Cheng CM
    Trends Biotechnol; 2018 Mar; 36(3):290-303. PubMed ID: 29242004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retinal imaging biomarkers of neurodegenerative diseases.
    Christinaki E; Kulenovic H; Hadoux X; Baldassini N; Van Eijgen J; De Groef L; Stalmans I; van Wijngaarden P
    Clin Exp Optom; 2022 Mar; 105(2):194-204. PubMed ID: 34751086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.